Current status of cardiovascular risk factor control: are we meeting the targets?

Lucrecia Maria Burgos1, Juan Pablo Costabel1, Paola Ramos Cano2

  • 1Instituto Cardiovascular de Buenos Aires, Argentine.

Insights

Cardiovascular risk factor control is poor globally, with many patients not meeting targets due to clinical inertia and adherence issues. Addressing psychosocial factors is key to improving cardiovascular prevention and reducing residual risk.

Area of Science:

  • Cardiology and Public Health
  • Preventive Medicine

Background:

  • Cardiovascular risk factor management, including hypertension, diabetes, dyslipidemia, and smoking, remains suboptimal worldwide.
  • Despite evidence-based guidelines and pharmacologic advances, clinical inertia, poor adherence, and health system barriers hinder effective control.
  • A significant gap exists between recommended targets and real-world practice for key modifiable determinants.

Purpose of the Study:

  • To review current evidence on cardiovascular risk factor control.
  • To quantify treatment gaps for both conventional and nonconventional risk factors.
  • To identify strategies for integrated, patient-centered care to reduce residual cardiovascular risk.

Main Methods:

  • Literature review synthesizing current evidence on cardiovascular risk factors.
  • Analysis of treatment gaps across various risk determinants.
  • Identification of opportunities for improving patient-centered cardiovascular prevention.

Main Results:

  • Fewer than half of patients achieve recommended targets for major modifiable cardiovascular risk factors.
  • Clinical inertia, limited patient adherence, and systemic barriers are primary contributors to suboptimal control.
  • Non-biological factors significantly widen the gap between guidelines and practice.

Conclusions:

  • Effective cardiovascular prevention requires addressing psychosocial factors alongside traditional risk determinants.
  • Integrated, patient-centered strategies are essential for reducing residual cardiovascular risk.
  • Improving control of hypertension, diabetes, dyslipidemia, and smoking is critical for global cardiovascular health.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...